In Reply to Sari et al

Affiliations

¹ Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California; Center for Precision Radiation Medicine, La Jolla, California.
² Department of Family Medicine and Public Health and Department of Mathematics, University of California San Diego, La Jolla, California.
³ Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Gynecologic Oncology, University of California San Diego, La Jolla, California.

Comment

Loren K Mell et al. Int J Radiat Oncol Biol Phys. 2020.

. 2020 Nov 15;108(4):1116-1117.

doi: 10.1016/j.ijrobp.2020.05.044.

¹ Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California; Center for Precision Radiation Medicine, La Jolla, California.
² Department of Family Medicine and Public Health and Department of Mathematics, University of California San Diego, La Jolla, California.
³ Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Gynecologic Oncology, University of California San Diego, La Jolla, California.

No abstract available

Comment on

Phase 1 Trial of Concurrent Gemcitabine and Cisplatin with Image Guided Intensity Modulated Radiation Therapy for Locoregionally Advanced Cervical Carcinoma.
Mell LK, Xu R, Yashar CM, McHale MT, Einck JP, Mayadev J, Lee E, Binder P, Rash D, Eskander R, Heide ES, Plaxe SC, Mundt AJ, Saenz CC. Mell LK, et al. Int J Radiat Oncol Biol Phys. 2020 Aug 1;107(5):964-973. doi: 10.1016/j.ijrobp.2020.04.019. Epub 2020 Apr 22. Int J Radiat Oncol Biol Phys. 2020. PMID: 32334034 Free PMC article. Clinical Trial.
In Regard to Mell et al.
Yuce Sari S, Gultekin M, Yildiz F. Yuce Sari S, et al. Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):1115-1116. doi: 10.1016/j.ijrobp.2020.05.045. Int J Radiat Oncol Biol Phys. 2020. PMID: 33069340 No abstract available.